Physician profile
Berthold Beisel
NPI 1174546345
$533.76
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.44 · 2022: $180 · 2023: $50.63 · 2024: $119 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $187.62 | 2022-2025 | |
| Lilly USA, LLC | $91.72 | 2024-2025 | Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $70.22 | 2022-2024 | Breztri, Farxiga |
| Abbott Laboratories | $49.39 | 2025 | Eterna, Proclaim |
| Novo Nordisk INC | $34.44 | 2023 | Rybelsus, Ozempic |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.60 | 2022 | |
| Exact Sciences Corporation | $15.41 | 2024 | Cologuard Collection Kit |
| Bausch Health US, LLC | $14.44 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.37 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $13.43 | 2024 | Voquezna |
| Scynexis, INC. | $12.87 | 2022 | |
| Pfizer INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berthold Beisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.